These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34655499)
1. Metal-Organic-Framework-Based Hydrogen-Release Platform for Multieffective Helicobacter Pylori Targeting Therapy and Intestinal Flora Protective Capabilities. Zhang W; Zhou Y; Fan Y; Cao R; Xu Y; Weng Z; Ye J; He C; Zhu Y; Wang X Adv Mater; 2022 Jan; 34(2):e2105738. PubMed ID: 34655499 [TBL] [Abstract][Full Text] [Related]
2. Metal-Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection. Zhou Y; Zhang W; He C; Shu C; Xu X; Wang H; Fei X; Li N; Hu Y; Xie C; Lu N; Wang X; Zhu Y Small; 2024 Jun; 20(24):e2308286. PubMed ID: 38431926 [TBL] [Abstract][Full Text] [Related]
3. Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514 [No Abstract] [Full Text] [Related]
4. Gastric Acid-Responsive ROS Nanogenerators for Effective Treatment of Helicobacter pylori Infection without Disrupting Homeostasis of Intestinal Flora. Yu J; Guo Z; Yan J; Bu C; Peng C; Li C; Mao R; Zhang J; Wang Z; Chen S; Yao M; Xie Z; Yang C; Yang YY; Yuan P; Ding X Adv Sci (Weinh); 2023 Jul; 10(20):e2206957. PubMed ID: 37127895 [TBL] [Abstract][Full Text] [Related]
5. Metal-organic-framework-based sitagliptin-release platform for multieffective radiation-induced intestinal injury targeting therapy and intestinal flora protective capabilities. He D; Li Z; Wang M; Kong D; Guo W; Xia X; Li D; Zhou D J Nanobiotechnology; 2024 Oct; 22(1):631. PubMed ID: 39415273 [TBL] [Abstract][Full Text] [Related]
6. Long-standing gastric mucosal barrier dysfunction in Helicobacter pylori-induced gastritis in mongolian gerbils. Sun YQ; Söderholm JD; Petersson F; Borch K Helicobacter; 2004 Jun; 9(3):217-27. PubMed ID: 15165257 [TBL] [Abstract][Full Text] [Related]
7. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection. Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843 [TBL] [Abstract][Full Text] [Related]
8. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa]. Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262 [TBL] [Abstract][Full Text] [Related]
9. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients. Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N World J Gastroenterol; 2005 Feb; 11(7):976-81. PubMed ID: 15742399 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Kuipers EJ Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():71-88. PubMed ID: 9146793 [TBL] [Abstract][Full Text] [Related]
12. How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer. Dhar P; Ng GZ; Sutton P Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G514-20. PubMed ID: 27469367 [TBL] [Abstract][Full Text] [Related]
14. [The changes of matrix metalloproteinase-9 expression in the gastric antral mucosa after Helicobacter pylori eradication: immunohistochemical study]. Ahn HS; Kim IH; Lee SO; Kang MJ; Kim DG; Lee ST Korean J Gastroenterol; 2004 Feb; 43(2):90-5. PubMed ID: 14978365 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing. Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093 [TBL] [Abstract][Full Text] [Related]
16. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults. He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220 [TBL] [Abstract][Full Text] [Related]
17. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury. Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309 [TBL] [Abstract][Full Text] [Related]
18. [The heterogeneity of genetic variants of Helicobacter pylori in patients with various acid-related diseases]. Domracheva EV; Sarsenbaeva AS; Ufimtsev KA Eksp Klin Gastroenterol; 2014; (11):8-13. PubMed ID: 25842656 [TBL] [Abstract][Full Text] [Related]
19. Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice. de Assumpção PP; Araújo TMT; de Assumpção PB; Barra WF; Khayat AS; Assumpção CB; Ishak G; Nunes DN; Dias-Neto E; Coelho LGV Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1591-1597. PubMed ID: 31114971 [TBL] [Abstract][Full Text] [Related]
20. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Bergin PJ; Anders E; Sicheng W; Erik J; Jennie A; Hans L; Pierre M; Qiang PH; Marianne QJ Helicobacter; 2004 Jun; 9(3):201-10. PubMed ID: 15165255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]